Related Experiment Video
Updated: Jun 6, 2025

X-Ray Crystallography to Study the Oligomeric State Transition of the Thermotoga maritima M42 Aminopeptidase TmPep1050
Published on: May 13, 2020
Crystal structure of glutamyl-tRNA synthetase from Helicobacter pylori
Dylan E Davis1, Jesuferanmi P Ayanlade2, David T Laseinde2
1College of Arts and Science, Dartmouth College, Hanover, NH 03755, USA.
Insights
Developing new treatments for Helicobacter pylori infection is crucial due to rising drug resistance. Researchers determined the structure of H. pylori Glutamyl-tRNA synthetase (HpGluRS), a potential drug target, revealing similarities to other bacterial enzymes for drug development.
Area of Science:
- Microbiology
- Structural Biology
- Drug Discovery
Background:
- Helicobacter pylori infection affects over two-thirds of the global population, leading to gastric ulcers and cancers.
- Increasing antibiotic resistance necessitates the development of alternative therapeutic strategies against H. pylori.
Purpose of the Study:
- To investigate Glutamyl-tRNA synthetase (GluRS) from H. pylori as a potential drug target.
- To determine the apo structure of H. pylori GluRS (HpGluRS) for structure-function analysis.
Main Methods:
- Production and crystallization of HpGluRS.
- Determination of the apo structure of HpGluRS using X-ray crystallography.
- Comparative analysis of HpGluRS structure with other bacterial GluRS enzymes.
Main Results:
- The apo structure of HpGluRS was successfully determined.
- HpGluRS exhibits a typical bacterial GluRS topology with conserved binding sites and tertiary structures.
- Key residues for glutamate binding in HpGluRS are conserved compared to Pseudomonas aeruginosa GluRS (PaGluRS).
Conclusions:
- HpGluRS is a viable drug target for developing new antibacterials.
- Structural similarities between HpGluRS and PaGluRS can guide the design of novel inhibitors.
- Exploiting these similarities may lead to effective treatments for H. pylori infections, reducing associated gastric diseases.
Abstract:
Helicobacter pylori is one of the most common bacterial infections; over two-thirds of the world's population is infected by early childhood. Persistent H. pylori infection results in gastric ulcers and cancers. Due to drug resistance, there is a need to develop alternative treatments to clear H. pylori. The Seattle Structural Genomics Center for Infectious Disease (SSGCID) conducts structure-function analysis of potential therapeutic targets from H. pylori. Glutamyl-tRNA synthetase (GluRS) is essential for tRNA aminoacylation and is under investigation as a bacterial drug target. The SSGCID produced, crystallized and determined the apo structure of H. pylori GluRS (HpGluRS). HpGluRS has the prototypical bacterial GluRS topology and has similar binding sites and tertiary structures to other bacterial GluRS that are promising drug targets. Residues involved in glutamate binding are well conserved in comparison with Pseudomonas aeruginosa GluRS (PaGluRS), which has been studied to develop promising new inhibitors for P. aeruginosa. These structural similarities can be exploited for drug discovery and repurposing to generate new antibacterials to clear persistent H. pylori infection and reduce gastric ulcers and cancer.
More Related Videos
09:31PCR Mutagenesis, Cloning, Expression, Fast Protein Purification Protocols and Crystallization of the Wild Type and Mutant Forms of Tryptophan Synthase
Published on: September 26, 2020
11:31Crystal Structure of the N-terminal Domain of Ryanodine Receptor from Plutella xylostella
Published on: November 30, 2018
Related Concept Videos
tRNA Activation
Protein Organization
Protein and Protein Structure
A protein's shape is critical to its function. For example, an enzyme...
RNA Structure
Different Types of RNA Have the Same Basic Structure
There are three main types of ribonucleic acid (RNA) involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). All three...
Protein Folding
Termination of Translation